The role of circulating neutrophils in the progression of kidney cancer

Introduction. Currently, the question of the role of neutrophils in the progression of kidney cancer remains relevant. Neutrophils are capable of exhibiting protumor properties through the secretion of cytokines, chemokines, and growth factors, which is determined by the expression of genes for thes...

Full description

Saved in:
Bibliographic Details
Main Authors: I. R. Magdieva, T. V. Abakumova, D. R. Dolgova, O. Y. Gorshkov, T. P. Gening
Format: Article
Language:Russian
Published: ABV-press 2024-04-01
Series:Успехи молекулярной онкологии
Subjects:
Online Access:https://umo.abvpress.ru/jour/article/view/652
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850025238133211136
author I. R. Magdieva
T. V. Abakumova
D. R. Dolgova
O. Y. Gorshkov
T. P. Gening
author_facet I. R. Magdieva
T. V. Abakumova
D. R. Dolgova
O. Y. Gorshkov
T. P. Gening
author_sort I. R. Magdieva
collection DOAJ
description Introduction. Currently, the question of the role of neutrophils in the progression of kidney cancer remains relevant. Neutrophils are capable of exhibiting protumor properties through the secretion of cytokines, chemokines, and growth factors, which is determined by the expression of genes for these molecules. And the functional heterogeneity of neutrophils is characterized by differences in gene expression patterns.Aim. To assess the role of circulating neutrophils in the progression of kidney cancer.Materials and methods. In circulating neutrophils of patients with verified clear cell kidney cancer at stages I–III according to Tumor, Nodus and Metastasis (TNM) (n = 88) before surgical treatment and conditionally healthy donors (control group) (n = 20), the expression of NGAL genes was determined using quantitative reverse transcription polymerase chain reaction, MMP-13 and VEGF-A.Results. There was an increase in NGAL gene expression in circulating neutrophils (p = 0.05) at the initial stage and a decrease in it at advanced stages of kidney cancer (p = 0.03). High expression of the MMP-13 gene by circulating neutrophils was detected at all stages of kidney cancer relative to control values (at stage I p = 0.005; at stage II p = 0.003; at stage III p = 0.0008). A significant direct correlation was observed between the expression of the NGAL and MMP-13 genes in neutrophils at stage I kidney cancer (r = 0.696; p = 0.003). In the group of patients with kidney cancer, a direct correlation was found between the expression of the NGAL and VEGF-A genes (r = 0.322; p = 0.049). A multivariable Cox regression model for disease-free survival revealed the predictive value of VEGF-A and NGAL genes expression in circulating neutrophils. With an increase in the expression of the VEGF-A and NGAL genes in neutrophils by 1 unit, the risk of metastases increases by 0.80 (0.65–0.99; p = 0.043) and 1.42 (1.01–2.00; p = 0.046) times, respectively. The Kaplan–Meier analysis of disease-free survival in patients with kidney cancer showed the influence of NGAL expression in circulating neutrophils on progression-free time. In the group of patients with high NGAL expression, the median follow-up was 31.7 months, and in the group with low NGAL expression – more than 36 months (log-rank-test; p = 0.017).Conclusion. Thus, the data obtained suggest that circulating neutrophils play a leading role in the progression of kidney cancer. The level of expression of NGAL in circulating neutrophils can be used to predict the relapse-free period in patients with kidney cancer.
format Article
id doaj-art-d55becc537c64e2b9fa1e5edfd58fa96
institution DOAJ
issn 2313-805X
2413-3787
language Russian
publishDate 2024-04-01
publisher ABV-press
record_format Article
series Успехи молекулярной онкологии
spelling doaj-art-d55becc537c64e2b9fa1e5edfd58fa962025-08-20T03:00:54ZrusABV-pressУспехи молекулярной онкологии2313-805X2413-37872024-04-011119910410.17650/2313-805X-2024-11-1-99-104321The role of circulating neutrophils in the progression of kidney cancerI. R. Magdieva0T. V. Abakumova1D. R. Dolgova2O. Y. Gorshkov3T. P. Gening4Ulyanovsk State UniversityUlyanovsk State UniversityUlyanovsk State UniversityRegional Clinical Oncological DispensaryUlyanovsk State UniversityIntroduction. Currently, the question of the role of neutrophils in the progression of kidney cancer remains relevant. Neutrophils are capable of exhibiting protumor properties through the secretion of cytokines, chemokines, and growth factors, which is determined by the expression of genes for these molecules. And the functional heterogeneity of neutrophils is characterized by differences in gene expression patterns.Aim. To assess the role of circulating neutrophils in the progression of kidney cancer.Materials and methods. In circulating neutrophils of patients with verified clear cell kidney cancer at stages I–III according to Tumor, Nodus and Metastasis (TNM) (n = 88) before surgical treatment and conditionally healthy donors (control group) (n = 20), the expression of NGAL genes was determined using quantitative reverse transcription polymerase chain reaction, MMP-13 and VEGF-A.Results. There was an increase in NGAL gene expression in circulating neutrophils (p = 0.05) at the initial stage and a decrease in it at advanced stages of kidney cancer (p = 0.03). High expression of the MMP-13 gene by circulating neutrophils was detected at all stages of kidney cancer relative to control values (at stage I p = 0.005; at stage II p = 0.003; at stage III p = 0.0008). A significant direct correlation was observed between the expression of the NGAL and MMP-13 genes in neutrophils at stage I kidney cancer (r = 0.696; p = 0.003). In the group of patients with kidney cancer, a direct correlation was found between the expression of the NGAL and VEGF-A genes (r = 0.322; p = 0.049). A multivariable Cox regression model for disease-free survival revealed the predictive value of VEGF-A and NGAL genes expression in circulating neutrophils. With an increase in the expression of the VEGF-A and NGAL genes in neutrophils by 1 unit, the risk of metastases increases by 0.80 (0.65–0.99; p = 0.043) and 1.42 (1.01–2.00; p = 0.046) times, respectively. The Kaplan–Meier analysis of disease-free survival in patients with kidney cancer showed the influence of NGAL expression in circulating neutrophils on progression-free time. In the group of patients with high NGAL expression, the median follow-up was 31.7 months, and in the group with low NGAL expression – more than 36 months (log-rank-test; p = 0.017).Conclusion. Thus, the data obtained suggest that circulating neutrophils play a leading role in the progression of kidney cancer. The level of expression of NGAL in circulating neutrophils can be used to predict the relapse-free period in patients with kidney cancer.https://umo.abvpress.ru/jour/article/view/652circulating neutrophilskidney cancerangiogenesisngalvegf-ammp-13
spellingShingle I. R. Magdieva
T. V. Abakumova
D. R. Dolgova
O. Y. Gorshkov
T. P. Gening
The role of circulating neutrophils in the progression of kidney cancer
Успехи молекулярной онкологии
circulating neutrophils
kidney cancer
angiogenesis
ngal
vegf-a
mmp-13
title The role of circulating neutrophils in the progression of kidney cancer
title_full The role of circulating neutrophils in the progression of kidney cancer
title_fullStr The role of circulating neutrophils in the progression of kidney cancer
title_full_unstemmed The role of circulating neutrophils in the progression of kidney cancer
title_short The role of circulating neutrophils in the progression of kidney cancer
title_sort role of circulating neutrophils in the progression of kidney cancer
topic circulating neutrophils
kidney cancer
angiogenesis
ngal
vegf-a
mmp-13
url https://umo.abvpress.ru/jour/article/view/652
work_keys_str_mv AT irmagdieva theroleofcirculatingneutrophilsintheprogressionofkidneycancer
AT tvabakumova theroleofcirculatingneutrophilsintheprogressionofkidneycancer
AT drdolgova theroleofcirculatingneutrophilsintheprogressionofkidneycancer
AT oygorshkov theroleofcirculatingneutrophilsintheprogressionofkidneycancer
AT tpgening theroleofcirculatingneutrophilsintheprogressionofkidneycancer
AT irmagdieva roleofcirculatingneutrophilsintheprogressionofkidneycancer
AT tvabakumova roleofcirculatingneutrophilsintheprogressionofkidneycancer
AT drdolgova roleofcirculatingneutrophilsintheprogressionofkidneycancer
AT oygorshkov roleofcirculatingneutrophilsintheprogressionofkidneycancer
AT tpgening roleofcirculatingneutrophilsintheprogressionofkidneycancer